Starling Oncology STLN
NASDAQ STLN
$5.95 -0.14 (-2.30%)
As of: Sep 3, 2026 · 2:44 PM EDT

Starling Oncology (STLN) Income from Continuing Operations (2020 - 2026)

Analysis

Starling Oncology (STLN) Income from Continuing Operations (2020 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 HCA Healthcare 90.68 Bn 89.67 Bn 15.19 Bn 1.93 Bn
2 Tenet Healthcare 22.03 Bn 19.86 Bn 4.45 Bn 1.05 Bn
3 Encompass Health 12.07 Bn 11.93 Bn 1.34 Bn 208.00 Mn
4 Davita 11.73 Bn 11.05 Bn 1.16 Bn 343.22 Mn
5 Universal Health Services 10.15 Bn 10.01 Bn 3.29 Bn 364.59 Mn
6 Ensign 9.95 Bn 9.63 Bn 306.24 Mn 99.83 Mn
7 Chemed 6.91 Bn 6.87 Bn 221.47 Mn 67.70 Mn
8 Pacs 6.68 Bn 6.51 Bn 338.46 Mn 76.35 Mn
9 Concentra Group Holdings Parent 4.30 Bn 4.14 Bn 192.10 Mn 67.30 Mn
10 Starling Oncology 613.04 Mn 571.94 Mn 27.17 Mn -9.79 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -9.79 Mn
Mar 31, 2026 -2.49 Mn
Dec 31, 2025 -7.51 Mn
Sep 30, 2025 -16.50 Mn
Jun 30, 2025 -17.01 Mn
Mar 31, 2025 -19.59 Mn
Dec 31, 2024 -13.18 Mn
Sep 30, 2024 -16.11 Mn
Jun 30, 2024 -15.48 Mn
Mar 31, 2024 -19.89 Mn
Dec 31, 2023 -18.75 Mn
Sep 30, 2023 -17.42 Mn
Jun 30, 2023 -16.90 Mn
Mar 31, 2023 -30.00 Mn
Dec 31, 2022 -11.01 Mn
Sep 30, 2022 -2.67 Mn
Jun 30, 2022 -5.45 Mn
Mar 31, 2022 19.29 Mn
Dec 31, 2021 -10.16 Mn
Sep 30, 2021 -2.98 Mn